Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011490
Filing Date
2021-08-12
Accepted
2021-08-12 16:21:21
Documents
81
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20210630x10q.htm   iXBRL 10-Q 2133835
2 EX-31.1 aplt-20210630xex31d1.htm EX-31.1 9683
3 EX-31.2 aplt-20210630xex31d2.htm EX-31.2 9676
4 EX-32.1 aplt-20210630xex32d1.htm EX-32.1 6278
5 EX-32.2 aplt-20210630xex32d2.htm EX-32.2 5922
  Complete submission text file 0001558370-21-011490.txt   8107940

Data Files

Seq Description Document Type Size
6 EX-101.SCH aplt-20210630.xsd EX-101.SCH 62621
7 EX-101.CAL aplt-20210630_cal.xml EX-101.CAL 48722
8 EX-101.DEF aplt-20210630_def.xml EX-101.DEF 218907
9 EX-101.LAB aplt-20210630_lab.xml EX-101.LAB 507600
10 EX-101.PRE aplt-20210630_pre.xml EX-101.PRE 404859
11 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20210630x10q_htm.xml XML 1403884
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 211167879
SIC: 2834 Pharmaceutical Preparations